{"type":"video","version":"1.0","html":"<iframe src=\"https://www.loom.com/embed/e61b0ec5d4cf4c0d875ebfb5555b15c2\" frameborder=\"0\" width=\"1920\" height=\"1440\" webkitallowfullscreen mozallowfullscreen allowfullscreen></iframe>","height":1440,"width":1920,"provider_name":"Loom","provider_url":"https://www.loom.com","thumbnail_height":1440,"thumbnail_width":1920,"thumbnail_url":"https://cdn.loom.com/sessions/thumbnails/e61b0ec5d4cf4c0d875ebfb5555b15c2-b1b38c106a3cba14.gif","duration":243.947,"title":"PubMed Guide for Off-Label Cancer Studies 🧠","description":"In this Loom, I give a quick rundown of a PubMed research guide I compiled, because when my family members went through cancer, oncologists kept saying there were no studies for off label drugs like methylene blue, ivermectin, mebendazole, or fenbendazole. I found there are studies, but many oncologists simply were not aware of them. I also address where to source these reliably, and I recommend Fierce Health, a US licensed pharmacy and telehealth provider that ships nationwide with 24 7 RN access and medical guidance for dosing. I ask you to click through the guide and the orange PubMed links to read study synopses yourself."}